Skip to content

One third of TB cases in Eastern European HIV clinic survey multi-drug resistant

Anne Marie W Efsen, Copenhagen Centre for Health and Infectious Disease Research, speaking at HIV Glasgow. Image courtesy of HIV Drug Therapy Glasgow 2014 (hivglasgow.org)

Bedaquiline as part of tailored therapy for MDR- and XDR-TB achieves impressive culture conversion rates

Use of drug susceptibility testing to select therapy improves treatment outcomes in patients with MDR- and XDR-TB

Reduced treatment delays for people with drug-resistant TB and HIV co-infection through decentralised care and rapid Xpert MTB/RIF test

Reduced treatment delays for people with drug-resistant TB and HIV co-infection through decentralised care and rapid Xpert MTB/RIF test

Novel TB regimen could reduce treatment duration

Mel Spigelman and Dan Everitt  presenting at AIDS 2014. Photo by Liz Highleyman, hivandhepatitis.com

TB-HIV news from the 44th Union World Conference on Lung Health.

HIV associated with increased risk of MDR-TB

Eastern Europe facing quadruple epidemic while governments do nothing, warns UN Special Envoy

UN Secretary General's Special Envoy on HIV in eastern Europe and central Asia, Professor Michel Kazatchkine, speaking at the opening plenary session of the 14th European AIDS Conference. Photo by Liz Highleyman, hivandhepatitis,com

UK patients with MDR-TB have good outcomes but a quarter not receiving the recommended duration of therapy